Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance.
Ferro M, Lucarelli G, Bruzzese D, Di Lorenzo G, Perdonà S, Autorino R, Cantiello F, La Rocca R, Busetto GM, Cimmino A, Buonerba C, Battaglia M, Damiano R, De Cobelli O, Mirone V, Terracciano D.
Ferro M, et al. Among authors: la rocca r.
Oncotarget. 2017 Mar 14;8(11):18424-18434. doi: 10.18632/oncotarget.12906.
Oncotarget. 2017.
PMID: 27793023
Free PMC article.